Skip to content
TransMed — Volume 1 · Issue 1 · June 2026

Volume 1 · Issue 1 · June 2026

Open Access · Peer Reviewed · Quarterly

TransMed

Bridging basic discovery, engineering and clinical practice in translational medicine.

TransMed is an open access, peer-reviewed journal. The aim of TransMed is to serve the multidisciplinary community of biomedical engineering. Each quarterly issue of TransMed presents basic, clinical, and engineering research articles, reviews, highlights, editorials, correspondences and short communications in the interdisciplinary field of nanotechnology, biology, medicine and engineering, as well as strategies for disease prevention, diagnosis, treatment, and assessment.

ISSN
3117-3977
Owner
LEFENG
Frequency
Quarterly
Language
English
Submit your manuscript Explore the journal
Journal homepage Submission Guidelines News

0

Issues per year

0%

Open access

2029

APC waived until 2029

3117-3977

ISSN

About the journal

A quarterly forum for biomedical engineering

Aims & Scope

TransMed is an open access, peer-reviewed journal. The aim of TransMed is to serve the multidisciplinary community of biomedical engineering. Each quarterly issue of TransMed presents basic, clinical, and engineering research articles, reviews, highlights, editorials, correspondences and short communications in the interdisciplinary field of nanotechnology, biology, medicine and engineering, as well as strategies for disease prevention, diagnosis, treatment, and assessment.

Lefeng Wisdom (Shanghai) Technology Co., Ltd. — LEFENG TECH — is a publishing company dedicated to open-access, peer-reviewed journals in the medical and life sciences.

Journal homepage Submission website About Us
  • Open access by default — every article is immediately and permanently free to read.
  • Rigorous, impartial peer review supported by in-house scientific editors.
  • An international Editorial Board that spans basic science, engineering and clinical practice.
  • Transparent publishing ethics, aligned with international best practice.

Latest research

Highlights from recent issues

View all

For authors

Everything you need before you submit

All article publishing charges for manuscripts submitted before 30 March 2029 are fully waived.

Submission Guidelines

Article types, word limits, title page, abstract, keywords, highlights and graphical abstract requirements.

Read more

Publishing Ethics

Requirements for human and animal research, and clinical trial transparency.

Read more

Editorial & Peer Review

How the Editorial Board and in-house scientific editors handle your manuscript.

Read more

Owner

Lefeng Wisdom (Shanghai) Technology Co., Ltd.

Lefeng Wisdom (Shanghai) Technology Co., Ltd. — LEFENG TECH — is a publishing company dedicated to open-access, peer-reviewed journals in the medical and life sciences.

Read more

Ready to submit your work?

All article publishing charges for manuscripts submitted before 30 March 2029 are fully waived.

Submit a Manuscript Submission Guidelines